Winston-Salem, NC, United States of America

Timothy A Bertram

This inventor holds 10 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Tengion, Inc., Inregen, Regenmedtx, LLC. Active years: 2011-2021.

USPTO Granted Patents = 10 (Patent Applications = 6)

% Patents Active = 60.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 8.3

ph-index = 4

Forward Citations = 67(Granted Patents)

Location History:

Winston-Salem, NC (US) (2011 - 2018)
George Town, KY (2018 - 2021)
Grand Cayman, KY (2021)

Company Filing History:

Years Active: 2011-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11123372 - Bioactive renal cells for the treatment of chronic kidney disease (2021-09-21),

2. 11066666 - Bioactive renal cells (2021-07-20),

3. 10105392 - Isolated renal cells and uses thereof (2018-10-23),

4. 10077442 - Bioactive renal cells (2018-09-18),

5. 9271824 - Cell scaffold constructs (2016-03-01),

6. 9192629 - Isolated renal cells and uses thereof (2015-11-24),

7. 8696760 - Scaffolds for organ reconstruction and augmentation (2014-04-15),

8. 8337485 - Cell-scaffold constructs (2012-12-25),

9. 8318484 - Isolated renal cells and uses thereof (2012-11-27),

10. 7918897 - Scaffolds for organ reconstruction and augmentation (2011-04-05),

Title: Timothy A. Bertram: Innovator in Renal Cell Technology

Introduction

Timothy A. Bertram is a prominent inventor based in Winston-Salem, North Carolina, recognized for his significant contributions to the field of renal cell technology. With a total of ten patents to his name, Bertram has been at the forefront of developing solutions to combat chronic kidney disease, showcasing his commitment to innovation in medical science.

Latest Patents

Among Bertram's notable inventions are two recent patents focused on bioactive renal cells aimed at treating chronic kidney disease. The first patent outlines methods of using bioactive renal cell populations to provide regenerative effects to a native kidney. The second patent also addresses bioactive renal cell populations, detailing renal cell constructs and the methods for their creation and application. These innovations reflect his dedication to enhancing kidney health through innovative cellular technology.

Career Highlights

Throughout his career, Timothy A. Bertram has held key positions at various esteemed companies, including Tengion, Inc. and Inregen. His work at these organizations has played a crucial role in advancing research and development in the field of regenerative medicine, particularly related to kidney health and cell therapy.

Collaborations

Bertram has collaborated with notable colleagues in his field, including Manuel J. Jayo and Oluwatoyin A. Knight. These partnerships have contributed to a strong collaborative environment that fosters innovation and drives successful outcomes in research initiatives.

Conclusion

Timothy A. Bertram represents a significant figure in the realm of medical innovations, particularly pertaining to chronic kidney disease. His extensive patent portfolio and successful collaborations underscore his influence and commitment to advancing healthcare solutions through innovative inventions.